Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients

HIV-1-infected patients with suppressed plasma viral loads often require changes to their antiretroviral (ARV) therapy to manage drug toxicity and intolerance, to improve adherence, and to avoid drug interactions. In patients who have never experienced virologic failure while receiving ARV therapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, Sean E., Grant, Philip M., Shafer, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Therapy in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700066/
https://www.ncbi.nlm.nih.gov/pubmed/26677129
http://dx.doi.org/10.1007/s40265-015-0515-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700066/
https://www.ncbi.nlm.nih.gov/pubmed/26677129
http://dx.doi.org/10.1007/s40265-015-0515-6

Ejemplares similares